http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1db8cdf1857dfa44fec7ec231dc7292
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Vijver J. van de Vijver van de Vijver de Vijver |
| name | Marc J van de Vijver Marc J. van de Vijver Marc. J. van de Vijver |
| given-name | Marc J. van Marc J Marc. Marc J van de Marc J. |
| organization-name | Department of Pathology, Netherlands Cancer Institute and Amsterdam Medical Centre, Amsterdam, The Netherlands. From the Departments of Radiation Oncology and Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; EORTC Data Center, Brussels, Belgium; Departments of Surgery and Pathology, Centre Henri Becquerel, Rouen, Department of Pathology, C.R.L.C. Val D’Aurelle, Montpellier, and Department of Pathology, Institut Bergonié, Bordeaux, France; Clinical Oncology Unit, Guy’s Hospital, London, United Kingdom; and Department of Pathology, Istituto Nazionale dei Tumori, Milano, Italy. Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, Netherlands. Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands Department of Pathology, Academic Medical Centre, Amsterdam, the Netherlands From the *Department of Urology, Academic Medical Center, Amsterdam, the Netherlands; †Bracco Suisse SA, Geneva Research Centre and Manufacturing Site, Plan-les-Ouates, Switzerland; ‡Advice-US Consulting, Nernier, France; and §Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands. Cancer Center Amsterdam , Amsterdam , The Netherlands; Department of Pathology, Amsterdam UMC, location University of Amsterdam , Amsterdam , The Netherlands 10Division of Experimental Therapy and 2Diagnostic Oncology, and Department of Pathology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands Division of Diagnostic Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands Authors' Affiliations: 1Howard Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, New York; 2Academic Medical Center, Department of Pathology; 3Division of Experimental Therapy, 4Department of Molecular Biology, 5Division of Radiation Oncology, and 6Central Microarray Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands; Authors' Affiliations: 1Howard Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, New York; 2Academic Medical Center, Department of Pathology; 3Division of Experimental Therapy, 4Department of Molecular Biology, 5Division of Radiation Oncology, and 6Central Microarray Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands From the Division of Experimental Therapy, Division of Medical Oncology, Central Microarray Facility, Division of Diagnostic Oncology, Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands 2Experimental Therapy,; 5Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands; Department of Pathology Academic Medical Centre Amsterdam The Netherlands Division of Diagnostic Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands From the Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research and the Royal Marsden Hospital, and Department of Histopathology, Royal Free and University College Medical School, London; Department of Pathology, University of Edinburgh Medical School, Edinburgh; and CRC Genetic Epidemiology Unit, Strangeways Research Laboratories, Cambridge, United Kingdom; the Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam, the Netherlands; and Department of Genetic... Academic Medical Center, Department of Pathology, Meibergdreef 9, 1105AZ Amsterdam, Netherlands. Program in Epithelial Biology, Departments of Biochemistry, Health Research and Policy, and Pathology, and Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305; Departments of Diagnostic Oncology and Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Rosetta Inpharmatics, Seattle, WA 98109; and Norwegian Radium Hospital, 0310 Oslo, Norway From the Royal Marsden Hospital, London, United Kingdom; Sunnybrook and Women's College, Health Science Center, Toronto, Canada; Netherlands Cancer Institute, Amsterdam, the Netherlands; Centre Jean Perrin, Clermont-Ferrand, France; Klinikum Kassel, Kassel, Germany; Tokai University School of Medicine, Kanagawa, Japan; and Westmead Hospital, Westmead, New South Wales, Australia. Authors' Affiliations: 1Institut Curie; 2INSERM U900; 3CNRS, UMR 144, Paris; 4Ecole des Mines de Paris, Fontainebleau; 5INRIA, Saclay, France; 6Netherlands Cancer Institute; 7Amsterdam Medical Centrum, Amsterdam; 8Institute for Radiation Oncology Arnhem, Arnhem, The Netherlands; 9Department of Statistics, University of California, Berkeley, California; and 10Hôpital Fattouma Bourguiba, Monastir, Tunisia; Authors' Affiliations: 1Institut Curie; 2INSERM U900; 3CNRS, UMR 144, Paris; 4Ecole des Mines de Paris, Fontainebleau; 5INRIA, Saclay, France; 6Netherlands Cancer Institute; 7Amsterdam Medical Centrum, Amsterdam; 8Institute for Radiation Oncology Arnhem, Arnhem, The Netherlands; 9Department of Statistics, University of California, Berkeley, California; and 10Hôpital Fattouma Bourguiba, Monastir, Tunisia 4Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; From the Departments of Clinical OncologySurgery, Pathology, and Medical Statistics, Leiden University Medical Center, Leiden; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; and European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group (Data Center, Brussels, Belgium, and member institutions). Authors' Affiliations: 1Agendia BV; Divisions of 2Experimental Therapy and 3Medical Oncology and 4Department of Pathology, Netherlands Cancer Institute; 5Department of Pathology, Academic Medical Centre, Amsterdam, The Netherlands and 6Agendia, Inc., Huntington Beach, California Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands Department of Diagnostic Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology Amsterdam UMC University of Amsterdam Amsterdam The Netherlands Authors' Affiliations: 1Division of Experimental Therapy, 2Bioinformatics and Statistics, Department of Molecular Biology, Divisions of 3Radiation Oncology, and 4Diagnostic Oncology, The Netherlands Cancer Institute; and 5Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands; and 6Faculty of Electrical Engineering Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands Department of Pathology, Amsterdam UMC, Amsterdam, the Netherlands. Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC University of Amsterdam Amsterdam The Netherlands; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC VU University Amsterdam Amsterdam The Netherlands Departments of Diagnostic Oncology and Department of Pathology, Amsterdam UMC, Amsterdam, The Netherlands. |
Incoming Links
Total number of triples: 228.